Astrazeneca Pharma India Stock Sees 5.24% Increase, Outperforms Sector and Sensex.

Astrazeneca Pharma India, a midcap pharmaceutical company, saw a 5.24% increase in its stock price on October 29, 2024. The stock has been given a 'Hold' rating by MarketsMOJO, a leading stock market analysis platform.

The stock's performance today has outperformed the sector by 6.11%, indicating a positive trend for the company. After three consecutive days of falling, the stock has shown a reversal and gained in value. It reached an intraday high of Rs 7512.9, showing a 6.43% increase.

The stock has been highly volatile today, with an intraday volatility of 5.62%, calculated from the weighted average price. This could be attributed to the overall market conditions and investor sentiment.

In terms of moving averages, the stock is currently higher than its 5-day, 50-day, 100-day, and 200-day moving averages. However, it is lower than its 20-day moving average, indicating a mixed trend for the stock.

In comparison to the Sensex, Astrazeneca Pharma India has performed significantly better, with a 1-day performance of 5.40% compared to Sensex's 0.45%. In the past month, the stock has also outperformed the Sensex, with a 3.54% increase compared to Sensex's -6.08% decrease.

Overall, Astrazeneca Pharma India's stock has shown a positive trend and has performed well in the past month. However, investors are advised to hold their positions and monitor the stock's performance closely.